Insider Selling at Procter & Gamble Draws Investor Scrutiny

Procter & Gamble sees significant insider selling by CEO and management, while Q2 earnings beat estimates but revenue misses. Institutional investors show mixed moves.

Recent regulatory filings reveal a notable wave of insider selling at consumer goods titan Procter & Gamble. The company's CEO, Jon R. Moeller, disposed of 173,268 shares in February. When combined with other management sales over the preceding 90 days, the total value of these transactions reaches approximately $55.5 million, a figure significant enough to capture the market's attention.

Financial Performance and Forward Guidance

The company's latest quarterly results presented a mixed financial picture. For the second quarter of its 2026 fiscal year, P&G reported earnings per share of $1.88, slightly surpassing analyst expectations of $1.86. However, revenue of $22.21 billion came in just short of the consensus estimate of $22.36 billion. Management has indicated it anticipates roughly $400 million in additional costs for the current fiscal year due to tariffs. The next quarterly report, scheduled for April 24, 2026, will be closely watched for signs of volume growth amidst persistent inflationary pressures.

Despite a gain of around 9% since the start of the year, P&G's share price remains substantially below its all-time high recorded in April 2025.

Institutional Holdings Show Divergent Strategies

The actions of major institutional investors do not paint a uniform picture. While Sanders Capital LLC reduced its stake by 3.6% to about 6.8 million shares in the third quarter, and FORA Capital LLC sold off 35.2% of its position, several other smaller firms initiated new positions or significantly increased their holdings. Overall, institutional investors continue to control 65.77% of P&G's outstanding shares.